San Antonio—Acelity may become a public company again, eight years after a consortium of private equity firms took the company, then known as Kinetic Concepts, private.
Bardy Diagnostics, a Seattle-based business developing a cardiac monitor and arrhythmia detection device, announced this week it has raised $35.5 million from investors to hire additional salespeople and fund continued product development.
Bardy’s flagship device is an hourglass-shaped patch that... Read more »
Humatics, a Waltham, MA-based startup developing microlocation technology for use in robots and autonomous vehicles, has a new partnership underway with Boston-based Vecna Robotics.
Financial terms of the collaboration were not disclosed, but Humatics co-founder and CEO David Mindell describes... Read more »
As hospitals and clinics have shifted from paper-based records to digital systems, one of the biggest challenges has been sharing patient data between healthcare providers, and between providers and outside software applications. This “interoperability” problem has created a market for companies... Read more »
Arrakis Therapeutics has been scouting elusive pharmaceutical quarry: small molecules able to “drug” RNA, the molecular messengers that carry the genetic instructions for proteins. Most drugs in use today act on proteins. But CEO Michael Gilman says targeting the genetic blueprints... Read more »
Houston—Sensors that can measure rising waters in real time through internet-connected digital road signs, preventing commuters from driving into flooded underpasses.
Traffic signals that use cameras and analytics to adjust the time allowed to cross streets, depending on the individual... Read more »
As the healthcare industry continues to undergo technology-driven changes, innovators in digital health and medical devices will gather in Detroit Thursday for a daylong conference.
AI-for-disease-diagnosis startup PathAI closed a $60 million Series B round led by New York-based growth equity investor General Atlantic to improve its “pathology research platform” and fuel development into “new tools and medical devices.”
PathAI partners with pharmaceutical companies and diagnostic... Read more »
There are many front lines in the battle to secure cyberspace for any given business: hackers, nation states, corporate espionage, supply chain security, AI-powered cyber tools, and ratcheting-up risks with the Internet of Things.
All these facets—together with the tech companies... Read more »
Wireless giant Qualcomm and smartphone maker Apple have been publicly feuding in courts around the globe, accusing one another of illegal business practices for more than two years.
Another tech “unicorn”—privately controlled startups valued at $1 billion or more—has been minted following sales software company Outreach’s latest venture funding round, a $114 million deal.
In the development of self-driving cars, once a vehicle is ready for the validation stage, it’s not always practical or affordable to test them on open roads. Given the hundreds of different scenarios developers want autonomous vehicles to experience and react... Read more »
The gene therapy boom. The frustration of failure after failure in Alzheimer’s disease. The critical interplay between venture firms and “crossover” investors in a volatile, unpredictable macro-environment. The growing need for (and role of) diversity initiatives within the... Read more »
Austin—EverlyWell, an Austin-based startup developing at-home health and wellness tests for patients, announced that it has raised $50 million in a Series B round of funding.
The investment was led by existing investor Goodwater Capital and newcomer Highland Capital Partners,... Read more »
Showdigs, a Seattle-based startup developing software to help prospective leasers schedule tours of apartments property managers have for rent, says it has raised $3 million in new funding to support its continued growth.
A local investor, Bellevue, WA-based Trilogy Equity... Read more »
While fungal infections may seem like an annoyance rather than a serious health problem, sick people in hospitals and long-term care facilities are contracting potentially deadly infections that current treatments are failing to ameliorate, thanks to the evolution of many such... Read more »
Achaogen wants to sell itself through an auction as a part of a Chapter 11 bankruptcy reorganization, which the antibacterial-product maker announced it filed for this morning.
Achaogen plans to continue its normal business operations through the Chapter 11 process and... Read more »
Vice President for Corporate Engagement, Rose-Hulman Institute of Technology
Director, Life Sciences Institute, University of Michigan
CEO of the Marine Bio-Technologies Center of Innovation
Founder, Young Inventors
Managing Director, D.E. Shaw and Co., L.P.